A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis

Affiliations

¹ Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
² Department of Dermatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.
³ Shandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong 250022, China.
⁴ Department of Dermatology, Shandong University Qilu Hospital, Jinan, Shandong 250012, China.
⁵ Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, China.
⁶ Beijing Wenfeng Tian Ji Pharma Ltd., Beijing 100044, China.
⁷ Zhonghao Pharmaceutical, Zhongshan, Guangdong 528437, China.

Clinical Trial

Lin Cai et al. Chin Med J (Engl). 2023.

. 2023 Jan 20;136(2):251-252.

doi: 10.1097/CM9.0000000000002489.

¹ Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
² Department of Dermatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.
³ Shandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong 250022, China.
⁴ Department of Dermatology, Shandong University Qilu Hospital, Jinan, Shandong 250012, China.
⁵ Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, China.
⁶ Beijing Wenfeng Tian Ji Pharma Ltd., Beijing 100044, China.
⁷ Zhonghao Pharmaceutical, Zhongshan, Guangdong 528437, China.

No abstract available

Conflict of interest statement

None.

1. Beck LA, Cork MJ, Amagai M, De Benedetto A, Kabashima K, Hamilton JD, et al. . Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov 2022; 2:100131.doi: 10.1016/j.xjidi.2022.100131. - PMC - PubMed
1. Cai L, Chen GH, Lu QJ, Zheng M, Li YZ, Chen J, et al. . A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis. Chin Med J 2020; 133:2905–2909. doi: 10.1097/CM9.0000000000001221. - PMC - PubMed
1. Smith SH, Jayawickreme C, Rickard DJ, Nicodeme E, Bui T, Simmons C, et al. . Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans. J Invest Dermatol 2017; 137:2110–2119. doi: 10.1016/j.jid.2017.05.004. - PubMed
1. Paller AS, Stein Gold L, Soung J, Tallman AM, Rubenstein DS, Gooderham M. Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis. J Am Acad Dermatol 2021; 84:632–638. doi: 10.1016/j.jaad.2020.05.135. - PubMed